SS Innovations International (NASDAQ:SSII) Trading Up 14.1% on Insider Buying Activity

SS Innovations International, Inc. (NASDAQ:SSII)’s stock price shot up 14.1% during mid-day trading on Wednesday after an insider bought additional shares in the company. The company traded as high as $5.10 and last traded at $5.0450. 53,240 shares traded hands during trading, a decline of 46% from the average session volume of 99,295 shares. The stock had previously closed at $4.42.

Specifically, CEO Srivastava Sudhir bought 498,753 shares of the firm’s stock in a transaction on Friday, March 6th. The shares were purchased at an average cost of $4.01 per share, with a total value of $1,999,999.53. Following the acquisition, the chief executive officer directly owned 109,851,767 shares in the company, valued at $440,505,585.67. This represents a 0.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy P. Adams bought 300,000 shares of the company’s stock in a transaction dated Friday, March 6th. The stock was purchased at an average price of $3.99 per share, with a total value of $1,197,000.00. Following the completion of the transaction, the director directly owned 5,331,902 shares in the company, valued at approximately $21,274,288.98. This represents a 5.96% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In other news, Director Frederic H. Moll purchased 501,253 shares of the business’s stock in a transaction dated Friday, March 6th. The stock was bought at an average price of $3.99 per share, with a total value of $1,999,999.47. Following the acquisition, the director owned 10,775,485 shares in the company, valued at approximately $42,994,185.15. The trade was a 4.88% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of SS Innovations International in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, SS Innovations International has a consensus rating of “Sell”.

Key SS Innovations International News

Here are the key news stories impacting SS Innovations International this week:

• Positive Sentiment: Multiple insiders bought material amounts of stock (CEO Srivastava ~498,753 shares; Director Timothy Adams 300,000 shares; Director Frederic Moll 501,253 shares), totaling ~1.3M shares and ~ $5.2M of purchases — a strong signal of management confidence. SEC filing: Srivastava purchase SEC filing: Adams purchase SEC filing: Moll purchase
• Positive Sentiment: Company reported Q4 and FY‑2025 results highlighting stronger SSi Mantra installations, procedures and revenue growth — supports the growth narrative as the company scales device adoption. GlobeNewswire: Q4/FY2025 results
• Positive Sentiment: Completed a private placement raising approximately $18.6M (5.77M shares, institutional and insider participation) to fund U.S./EU expansion and working capital while awaiting regulatory milestones. The financing reduces near‑term cash risk. GlobeNewswire: Private placement
• Neutral Sentiment: Some institutional investors have added positions recently, which may provide longer‑term support but won’t necessarily reduce short‑term volatility. QuiverQuant: placement/ownership summary
• Negative Sentiment: Reported EPS of ($0.01) for the quarter with a negative net margin (~32%) and negative ROE (~34%) — profitability remains a headwind and could limit multiple expansion until margins improve. GlobeNewswire: Q4/FY2025 results
• Negative Sentiment: The private placement issues 5.77M shares plus unregistered securities/warrants, creating dilution and potential downward pressure on the stock despite the capital raise. GlobeNewswire: Private placement terms
• Negative Sentiment: Company progress depends on regulatory outcomes (FDA 510(k) review and CE marking). Timing and approval risk keep shares volatile until clear regulatory wins occur. GlobeNewswire: regulatory timeline

SS Innovations International Stock Performance

The stock’s fifty day simple moving average is $4.80 and its two-hundred day simple moving average is $6.05. The stock has a market capitalization of $942.63 million and a P/E ratio of -80.83.

SS Innovations International (NASDAQ:SSII) last released its quarterly earnings results on Tuesday, March 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $14.53 million for the quarter. SS Innovations International had a negative net margin of 28.54% and a negative return on equity of 29.76%.

Institutional Trading of SS Innovations International

Institutional investors and hedge funds have recently bought and sold shares of the stock. Inspire Investing LLC grew its position in shares of SS Innovations International by 124.4% in the 4th quarter. Inspire Investing LLC now owns 82,773 shares of the company’s stock valued at $470,000 after buying an additional 45,886 shares during the last quarter. Eversept Partners LP bought a new position in shares of SS Innovations International during the fourth quarter worth about $428,000. Vontobel Holding Ltd. bought a new position in shares of SS Innovations International during the fourth quarter worth about $116,000. Jane Street Group LLC acquired a new position in shares of SS Innovations International in the fourth quarter worth approximately $63,000. Finally, IFC & Insurance Marketing Inc. acquired a new position in shares of SS Innovations International in the fourth quarter worth approximately $64,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.